Dominant-negative Suppression of HNF-1α Results in Mitochondrial Dysfunction, INS-1 Cell Apoptosis, and Increased Sensitivity to Ceramide-, but Not to High Glucose-induced Cell Death

H Wobser,H Dussmann,D Kogel,HY Wang,C Reimertz,CB Wollheim,MM Byrne,JHM Prehn
DOI: https://doi.org/10.1074/jbc.m108390200
IF: 5.485
2002-01-01
Journal of Biological Chemistry
Abstract:Maturity onset diabetes of the young (MODY) 3 is a monogenic form of diabetes caused by mutations in the transcription factor hepatocyte nuclear factor (HNF)-1α. We investigated the involvement of apoptotic events in INS-1 insulinoma cells overexpressing wild-type HNF-1α (WT-HNF-1α) or a dominant-negative mutant (DN-HNF-1α) under control of a doxycycline-dependent transcriptional activator. Forty-eight h after induction of DN-HNF-1α, INS-1 cells activated caspase-3 and underwent apoptotic cell death, while cells overexpressing WT-HNF-1α remained viable. Mitochondrial cytochromec release and activation of caspase-9 accompanied DN-HNF-1α-induced apoptosis, suggesting the involvement of the mitochondrial apoptosis pathway. Activation of caspases was preceded by mitochondrial hyperpolarization and decreased expression of the anti-apoptotic protein Bcl-xL. Transient overexpression of Bcl-xL was sufficient to rescue INS-1 cells from DN-HNF-1α-induced apoptosis. Both WT- and DN-HNF-1α-expressing cells demonstrated similar increases in apoptosis when cultured at high glucose (25 mm). In contrast, induction of DN-HNF-1α highly sensitized cells to ceramide toxicity. In cells cultured at low glucose, DN-HNF-1α induction also caused up-regulation of the cell cycle inhibitor p27KIP1. Therefore, our data indicate that increased sensitivity to the mitochondrial apoptosis pathway and decreased cell proliferation may account for the progressive loss of β-cell function seen in MODY 3 subjects.
What problem does this paper attempt to address?